CAS: 544478-19-5 - methyl 4-(3-dioxaziridin-3-ylphenyl)-5-(3-hydroxypropanoyl)-2,6-dimethyl-1-prop-2-yn-1-yl-1,4-dihydropyridine-3-carboxylate
Formula:C21H22N2O6
InChI:InChI=1/C21H22N2O6/c1-5-10-22-13(2)18(17(25)9-11-24)20(19(14(22)3)21(26)27-4)15-7-6-8-16(12-15)23-28-29-23/h1,6-8,12,20,24H,9-11H2,2-4H3
- Synonyms:
- 3-Pyridinecarboxylic acid, 4-[3-(3-dioxaziridinyl)phenyl]-1,4-dihydro-5-(3-hydroxy-1-oxopropyl)-2,6-dimethyl-1-(2-propyn-1-yl)-, methyl ester
- Methyl 4-[3-(dioxaziridin-3-yl)phenyl]-5-(3-hydroxypropanoyl)-2,6-dimethyl-1-(prop-2-yn-1-yl)-1,4-dihydropyridine-3-carboxylate
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MRS 1845 REF: 7W-GL8013CAS: 544478-19-5 | - - - | To inquire | Tue 10 Dec 24 |
 | MRS1845 REF: TM-T12108CAS: 544478-19-5 | 99.69% | To inquire | Tue 10 Dec 24 |
 | MRS 1845 REF: 3D-UWA47819CAS: 544478-19-5 | Min. 95% | 462.00 €~2,829.00 € | Mon 16 Dec 24 |
MRS1845
CAS:544478-19-5
MRS1845 is a selective inhibitor of store-operated calcium (SOC) channel (IC50 of 1.7 μM).
Formula:
C21H22N2O6
Purity:
99.69%
Color and Shape:
Solid
Molecular weight:
398.41
Ref: TM-T12108
| 1mg | 52.00 € | ||
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
MRS 1845
CAS:544478-19-5
MRS 1845 is a cytostatic drug that inhibits the growth of cancer cells by inhibiting …
Formula:
C21H22N2O6
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
398.41 g/mol
Ref: 3D-UWA47819
| 5mg | 462.00 € | ||
| 10mg | 657.00 € | ||
| 25mg | 1,105.00 € | ||
| 50mg | 1,768.00 € | ||
| 100mg | 2,829.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
